Article
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Jul 2021
McCracken James T, Anagnostou Evdokia, Arango Celso, Dawson Geraldine, Farchione Tiffany, Mantua Valentina, McPartland James, Murphy Declan, Pandina Gahan, Veenstra-VanderWeele Jeremy
Abstract excerpt
In 2017, facing lack of progress and failures encountered in targeted drug development for Autism Spectrum Disorder (ASD) and related neurodevelopmental disorders, the ISCTM with the ECNP created the ASD Working Group charged to identify barriers to progress and recommending research strategies for the field to gain traction. Working Group international academic, regulatory and industry representatives held...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.